Long-term outcomes and quality of life in patients with Hirschsprung disease

Mikko P Pakarinen1, Annika Mutanen1

  • 1Department of Pediatric Surgery, University of Helsinki Children's Hospital, Helsinki, Finland.

PubMed

Insights

Patients with Hirschsprung disease often experience long-term bowel dysfunction and other health issues. However, with effective management and an interdisciplinary approach, a good quality of life is achievable.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Urology
  • Genetics

Background:

  • Hirschsprung disease (HSCR) is a congenital condition characterized by aganglionosis of the distal bowel.
  • Long-term complications extend beyond bowel dysfunction, impacting urinary, sexual, and psychosocial health.
  • Associated comorbidities like inflammatory bowel disease and familial medullary thyroid cancer can emerge later in life.

Purpose of the Study:

  • To review the multifaceted long-term complications associated with Hirschsprung disease.
  • To emphasize the importance of a comprehensive, interdisciplinary management approach.
  • To highlight the need for continued research into pathophysiological mechanisms and novel therapies.

Main Methods:

  • Literature review of studies focusing on long-term outcomes in Hirschsprung disease patients.
  • Analysis of patient data regarding functional, medical, and psychosocial sequelae.
  • Synthesis of current management strategies and identification of research gaps.

Main Results:

  • Imperfect bowel function and fecal incontinence are common, but manageable.
  • Increased predisposition to lower urinary tract symptoms, sexual dysfunction, and infertility.
  • Psychosocial issues and decreased quality of life are significant concerns.
  • Rare comorbidities necessitate ongoing surveillance.

Conclusions:

  • Despite challenges, a good quality of life is attainable through effective bowel management and psychosocial support.
  • An interdisciplinary approach is crucial for optimal patient care and transition to adult healthcare.
  • Further research is essential to understand long-term bowel dysfunction and develop innovative treatments.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
126
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.4K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
70
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
3